alternatives to glp 1 agonists Comparing Ozempic, Wegovy and Other GLP-1 Drugs The GLP-1 Agonists and Obesity:
Description
Thomas, M
MF: Writing review & editing
Short-acting drugs primarily lower postprandial blood glucose levels by slowing gastric emptying, while long-acting GLP-1 RAs are more effective at reducing fasting blood glucose levels, mainly by promoting insulin secretion and inhibiting glucagon release
Novo Nordisk successfully completes the first phase 3a trial, PIONEER 1, with oral semaglutide
GLP-1RAs have shown promising results in treating non-alcoholic fatty liver disease (NAFLD) in patients with T2DM [51]
This could be the reason why the bispecific molecules work so well
